UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by U.S. Capital Wealth Advisors LLC

U.S. Capital Wealth Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.9% in the third quarter, HoldingsChannel reports. The firm owned 12,175 shares of the healthcare conglomerate’s stock after selling 2,134 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $7,118,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Key Client Fiduciary Advisors LLC bought a new position in shares of UnitedHealth Group in the first quarter worth $212,000. Wealthcare Advisory Partners LLC increased its stake in UnitedHealth Group by 6.3% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 5,512 shares of the healthcare conglomerate’s stock valued at $2,727,000 after buying an additional 326 shares during the period. Signet Financial Management LLC boosted its holdings in shares of UnitedHealth Group by 8.0% in the first quarter. Signet Financial Management LLC now owns 725 shares of the healthcare conglomerate’s stock valued at $358,000 after acquiring an additional 54 shares in the last quarter. Agate Pass Investment Management LLC raised its holdings in UnitedHealth Group by 25.2% during the first quarter. Agate Pass Investment Management LLC now owns 497 shares of the healthcare conglomerate’s stock worth $246,000 after purchasing an additional 100 shares in the last quarter. Finally, Janiczek Wealth Management LLC increased its position in shares of UnitedHealth Group by 4.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 1,814 shares of the healthcare conglomerate’s stock valued at $897,000 after purchasing an additional 82 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.9 %

NYSE:UNH opened at $564.48 on Thursday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company’s 50 day moving average is $584.16 and its 200-day moving average is $536.49. The firm has a market cap of $521.25 billion, a price-to-earnings ratio of 36.77, a P/E/G ratio of 1.67 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the company earned $6.56 EPS. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Stephens dropped their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, TD Cowen lifted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.